AAAAAA
Results: 1-25/67
Authors:
EK O
WAURZYNIAK B
MYERS DE
UCKUN FM
Citation: O. Ek et al., ANTITUMOR-ACTIVITY OF TP3(ANTI-P80)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN IN HAMSTER-CHEEK POUCH AND SEVERE COMBINED IMMUNODEFICIENT MOUSEXENOGRAFT MODELS OF HUMAN OSTEOSARCOMA, Clinical cancer research, 4(7), 1998, pp. 1641-1647
Authors:
NARLA RK
LIU XP
MYERS DE
UCKUN FM
Citation: Rk. Narla et al., O-4'HYDROXYLPHENYL)-AMINO-6,7-DIMETHOXYQUINAZOLINE - A NOVEL QUINAZOLINE DERIVATIVE WITH POTENT CYTOTOXIC ACTIVITY AGAINST HUMAN GLIOBLASTOMA CELLS, Clinical cancer research, 4(6), 1998, pp. 1405-1414
Authors:
UCKUN FM
NARLA RK
ZEREN T
YANISHEVSKI Y
MYERS DE
WAURZYNIAK B
EK O
SCHNEIDER E
MESSINGER Y
CHELSTROM LM
GUNTHER R
EVANS W
Citation: Fm. Uckun et al., IN-VIVO TOXICITY, PHARMACOKINETICS, AND ANTICANCER ACTIVITY OF GENISTEIN LINKED TO RECOMBINANT HUMAN EPIDERMAL GROWTH-FACTOR, Clinical cancer research, 4(5), 1998, pp. 1125-1134
Authors:
UCKUN FM
NARLA RK
ZEREN T
YANISHEVSKI Y
MYERS DE
WAURZYNIAK B
EK O
SCHNEIDER E
MESSINGER Y
CHELSTROM LM
GUNTHER R
EVANS W
Citation: Fm. Uckun et al., IN-VIVO TOXICITY, PHARMACOKINETICS, AND ANTICANCER ACTIVITY OF GENISTEIN LINKED TO RECOMBINANT HUMAN EPIDERMAL GROWTH-FACTOR, Clinical cancer research, 4(5), 1998, pp. 1125-1134
Authors:
UCKUN FM
NARLA RK
JUN X
ZEREN T
VENKATACHALAM T
WADDICK KG
ROSTOSTEV A
MYERS DE
Citation: Fm. Uckun et al., CYTOTOXIC ACTIVITY OF EPIDERMAL GROWTH FACTOR-GENISTEIN AGAINST BREAST-CANCER CELLS, Clinical cancer research, 4(4), 1998, pp. 901-912
Authors:
UCKUN FM
NARLA RK
JUN X
ZEREN T
VENKATACHALAM T
WADDICK KG
ROSTOSTEV A
MYERS DE
Citation: Fm. Uckun et al., CYTOTOXIC ACTIVITY OF EPIDERMAL GROWTH FACTOR-GENISTEIN AGAINST BREAST-CANCER CELLS, Clinical cancer research, 4(4), 1998, pp. 901-912
Authors:
MESSINGER Y
YANISHEVSKI Y
EK O
ZEREN T
WAURZYNIAK B
GUNTHER R
CHELSTROM L
CHANDANLANGLIE M
SCHNEIDER E
MYERS DE
EVANS W
UCKUN FM
Citation: Y. Messinger et al., IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43 (ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE IN NONHUMAN-PRIMATES, Clinical cancer research, 4(1), 1998, pp. 165-170
Authors:
MESSINGER Y
YANISHEVSKI Y
EK O
ZEREN T
WAURZYNIAK B
GUNTHER R
CHELSTROM L
CHANDANLANGLIE M
SCHNEIDER E
MYERS DE
EVANS W
UCKUN FM
Citation: Y. Messinger et al., IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43 (ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE IN NONHUMAN-PRIMATES, Clinical cancer research, 4(1), 1998, pp. 165-170
Authors:
EK O
GAYNON P
ZEREN T
CHELSTROM LM
MYERS DE
UCKUN FM
Citation: O. Ek et al., TREATMENT OF HUMAN B-CELL PRECURSOR LEUKEMIA IN SCID MICE BY USING A COMBINATION OF THE ANTI-CD19 IMMUNOTOXIN B43-PAP WITH THE STANDARD CHEMOTHERAPEUTIC DRUGS VINCRISTINE, METHYLPREDNISOLONE, AND L-ASPARAGINASE, Leukemia & lymphoma, 31(1-2), 1998, pp. 143-149
Authors:
EK O
YANISHEVSKI Y
ZEREN T
WAURZYNIAK B
GUNTHER R
CHELSTROM L
CHANDANLANGLIE M
SCHNEIDER E
MYERS DE
EVANS W
UCKUN FM
Citation: O. Ek et al., IN-VIVO TOXICITY AND PHARMACOKINETIC FEATURES OF B43(ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE, Leukemia & lymphoma, 30(3-4), 1998, pp. 389-394
Authors:
MYERS DE
SICHENEDER A
CLEMENTSON D
DVORAK N
VENKATACHALAM T
SEV AR
CHANDANLANGLIE M
UCKUN FM
Citation: De. Myers et al., LARGE-SCALE MANUFACTURING OF B43(ANTI-CD19)-GENISTEIN FOR CLINICAL-TRIALS IN LEUKEMIA AND LYMPHOMA, Leukemia & lymphoma, 29(3-4), 1998, pp. 329
Authors:
EK O
REAMAN GH
CRANKSHAW DL
CHELSTROM LM
MYERS DE
UCKUN FM
Citation: O. Ek et al., COMBINED THERAPEUTIC EFFICACY OF THE THYMIDYLATE SYNTHASE INHIBITOR ZD1694 (TOMUDEX) AND THE IMMUNOTOXIN B43(ANTI-CD19)-PAP IN A SCID MOUSEMODEL OF HUMAN B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia & lymphoma, 28(5-6), 1998, pp. 509-514
Authors:
UCKUN FM
CHELSTROM LM
TUELAHLGREN L
DIBIRDIK I
IRVIN JD
LANGLIE EC
MYERS DE
Citation: Fm. Uckun et al., TXU (ANTI-CD7)-POKEWEED ANTIVIRAL PROTEIN AS A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 383-388
Authors:
GUGGENHEIMER J
ORCHARD TJ
MOORE PA
MYERS DE
ROSSIE KM
Citation: J. Guggenheimer et al., RELIABILITY OF SELF-REPORTED HEART MURMUR HISTORY - POSSIBLE IMPACT ON ANTIBIOTIC USE IN DENTISTRY, The Journal of the American Dental Association, 129(7), 1998, pp. 861-866
Authors:
ROKO RO
DAEMEN JJK
MYERS DE
Citation: Ro. Roko et al., VARIOGRAM CHARACTERIZATION OF JOINT SURFACE-MORPHOLOGY AND ASPERITY DEFORMATION DURING SHEARING, International journal of rock mechanics and mining sciences, 34(1), 1997, pp. 71-84
Authors:
MYERS DE
Citation: De. Myers, ESTIMATING THE AREA AFFECTED BY PHOSPHORUS RUNOFF IN AN EVERGLADES WETLAND - A COMPARISON OF UNIVERSAL KRIGING AND BAYESIAN KRIGING - DISCUSSION, Environmental and ecological statistics, 4(1), 1997, pp. 27-28
Authors:
WAURZYNIAK B
SCHNEIDER EA
TUMER N
YANISHEVSKI Y
GUNTHER R
CHELSTROM LM
WENDORF H
MYERS DE
IRVIN JD
MESSINGER Y
EK O
ZEREN T
LANGLIE MC
EVANS WE
UCKUN FM
Citation: B. Waurzyniak et al., IN-VIVO TOXICITY, PHARMACOKINETICS, AND ANTILEUKEMIC ACTIVITY OF TXU (ANTI-CD7)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN, Clinical cancer research, 3(6), 1997, pp. 881-890
Authors:
UCKUN FM
YANISHEVSKI Y
TUMER N
WAURZYNIAK B
MESSINGER Y
CHELSTROM LM
LISOWSKI EA
EK O
ZEREN T
WENDORF H
LANGLIE MC
IRVIN JD
MYERS DE
FULLER GB
EVANS W
GUNTHER R
Citation: Fm. Uckun et al., PHARMACOKINETIC FEATURES, IMMUNOGENICITY, AND TOXICITY OF B43(ANTI-CD19)-POKEWEED ANTIVIRAL PROTEIN IMMUNOTOXIN IN CYNOMOLGUS MONKEYS, Clinical cancer research, 3(3), 1997, pp. 325-337
Authors:
PERENTESIS JP
GUNTHER R
WAURZYNIAK B
YANISHEVSKI Y
MYERS DE
EK O
MESSINGER Y
SHAO Y
CHELSTROM LM
SCHNEIDER E
EVANS WE
UCKUN FM
Citation: Jp. Perentesis et al., IN-VIVO BIOTHERAPY OF HL-60 MYELOID-LEUKEMIA WITH A GENETICALLY-ENGINEERED RECOMBINANT FUSION TOXIN DIRECTED AGAINST THE HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-RECEPTOR, Clinical cancer research, 3(12), 1997, pp. 2217-2227
Authors:
MYERS DE
JUN X
CLEMENTSON D
DONELSON R
SICHENEDER A
HOFFMAN N
BELL K
SARQUIS M
LANGLIE MC
TURNER N
UCKUN FM
Citation: De. Myers et al., LARGE-SCALE MANUFACTURING OF TXU(ANTI-CD7)-POKEWEED ANTIVIRAL PROTEIN(PAP) IMMUNOCONJUGATE FOR CLINICAL-TRIALS, Leukemia & lymphoma, 27(3-4), 1997, pp. 275-302
Authors:
LONG AE
MYERS DE
Citation: Ae. Long et De. Myers, A NEW FORM OF THE COKRIGING EQUATIONS, Mathematical geology, 29(5), 1997, pp. 685-703
Authors:
MYERS DE
SHAIKH Z
ZULLO T
Citation: De. Myers et al., ANALGESIC EFFECT OF CAFFEINE IN EXPERIMENTAL ISCHEMIC MUSCLE-CONTRACTION PAIN, Journal of dental research, 76, 1997, pp. 1070-1070
Authors:
MYERS DE
SHAIKH Z
ZULLO TG
Citation: De. Myers et al., HYPOALGESIC EFFECT OF CAFFEINE IN EXPERIMENTAL ISCHEMIC MUSCLE-CONTRACTION PAIN, Headache, 37(10), 1997, pp. 654-658
Authors:
PERRY KJ
QUIZA M
MYERS DE
MORFIS M
CHRISTOPOULOS G
SEXTON PM
Citation: Kj. Perry et al., CHARACTERIZATION OF AMYLIN AND CALCITONIN RECEPTOR-BINDING IN THE MOUSE ALPHA-THYROID-STIMULATING HORMONE THYROTROPH CELL-LINE, Endocrinology, 138(8), 1997, pp. 3486-3496
Authors:
MESSINGER Y
YANISHEVSKI Y
EK O
ZEREN T
WAURZYNIAK B
GUNTHER R
CHELSTROM L
CHANDANLANGLIE M
SCHNEIDER E
MYERS DE
UCKUN FM
Citation: Y. Messinger et al., IN-VIVO TOXICITY, PHARMACOKINETIC FEATURES AND IMMUNOGENICITY OF B43 (ANTI-CD19)-GENISTEIN IMMUNOCONJUGATE IN MICE AND NONHUMAN-PRIMATES, Blood, 90(10), 1997, pp. 1467-1467